Clinicopathological features of programmed cell death-1 and programmed cell death-ligand-1 expression in the tumor cells and tumor microenvironment of angioimmunoblastic T cell lymphoma and peripheral T cell lymphoma not otherwise specified.

导出原文传递

翻译打印收藏纠错

作者： Sehui,Kim ^[1] ; Dohee,Kwon ^[2] ; Jiwon,Koh ^[1] ; Soo Jeong,Nam ^[1] ; Young A,Kim ^[3] ; Tae Min,Kim ^[4] ; Chul Woo,Kim ^[5] ; Yoon Kyung,Jeon ^[1]

作者单位： Department of Pathology, Seoul National University Hospital, Seoul National University College of Medicine, 103 Daehak-ro, Jongno-gu, Seoul, 03080, Republic of Korea. ^[1] Cancer Research Institute, Seoul National University, 103 Daehak-ro, Jongno-gu, Seoul, 03080, Republic of Korea. ^[2] Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, Republic of Korea. ^[3] Department of Pathology, Seoul Metropolitan Government-Seoul National University Boramae Medical Center, 20 Boramae-ro 5-gil, Dongjak-gu, Seoul, 07061, Republic of Korea. ^[4] Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine, 103 Daehak-ro, Jongno-gu, Seoul, 03080, Republic of Korea. ^[5] Department of Pathology, Seoul National University Hospital, Seoul National University College of Medicine, 103 Daehak-ro, Jongno-gu, Seoul, 03080, Republic of Korea. ykjeon@snu.ac.kr. ^[6] Cancer Research Institute, Seoul National University, 103 Daehak-ro, Jongno-gu, Seoul, 03080, Republic of Korea. ykjeon@snu.ac.kr. ^[7]

关键词 Angioimmunoblastic T cell lymphoma Cancer immunotherapy Immune checkpoint Peripheral T cell lymphoma Programmed cell death-1 Programmed cell death-ligand-1